JUBLPHARMA.BOJUBLPHARMA.BOBSE
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank100
5Y CAGR+77.3%
Studio
Year-over-Year Change

Year-over-year net income growth rate

5Y CAGR
+77.3%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
17.5x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
2025988.72%
2024226.39%
2023-114.74%
2022-50.48%
2021-6.94%
202056.36%
2019-10.63%
201811.67%
201746.91%
2016778.33%